Administrative Supplement Request

New Research Funding Opportunity Offered by UC San Diego Altman Clinical Translational Research Institute

The National Center for Advancing Translational Sciences (NCATS) has announced the opportunity for CTSAs to submit an administrative supplement request to support new or ongoing bench-to-bedside translational research. Proposed projects must be completed within the currently approved project period for the existing parent award (3/31/20) and the requested project period may be up to two years.

In response to this announcement, UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is accepting proposals that are due two months in advance of the posted application due dates found here. These will be competitively reviewed, and if selected, will then be further developed into a supplement request not to exceed six pages. Final proposals will provide a detailed budget, the scope of the project, specific milestones for implementation, and the relationship of the supplement request to the parent CTSA grant.

Please contact Su-Yin Chang with questions. Proposals with accompanying biosketches of key investigators and an application form should be submitted to Su-Yin Chang with the subject heading “UC San Diego ACTRI Administrative Supplements.” Total costs of up to $300,000/year in direct costs may be requested. Membership in the ACTRI is required to be eligible for funding.

To access the funding application in MS Word or pdf

Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)

Translating biomedical discoveries into clinical applications is essential to improving human health. It is also a complex process with high costs and substantial failure rates. These failures can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research. The Clinical and Translational Science Award (CTSA) hubs promote advances in translational research and training at participating medical research institutions. This funding opportunity announcement (FOA) will enable innovative collaborations among CTSA hubs to overcome system-wide barriers to translational effectiveness.

In response to this announcement, UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is accepting proposals that are due two months in advance of the posted application due dates found here. These will be competitively reviewed, and if selected, will then be further developed into a full proposal. Final proposals will provide a detailed budget, the scope of the project, specific milestones for implementation, and the relationship of the supplement request to the parent CTSA grant.

Please contact Su-Yin Chang with questions. Proposals with accompanying biosketches of key investigators and an application form should be submitted to Su-Yin Chang with the subject heading “Collaborative Innovation Award.” For clinical projects, no more than $1,000,000 direct costs annual budget should be requested. For non-clinical projects, no more than $500,000 direct costs annual budget should be requested.

To access the funding application in MS Word or pdf